BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 20699513)

  • 1. Novel restriction enzyme SSiI for the detection of mutation in GyrA gene of Salmonella enterica serovar Typhi.
    Agrawal P; Kapila K; Kumar S; Ghosh AN; Maurya AK
    Indian J Pathol Microbiol; 2010; 53(3):509-12. PubMed ID: 20699513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
    Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
    J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of mutations in the gyrA gene in fluoroquinolone resistance Salmonella enterica serotypes typhi and paratyphi A isolated from the Infectious Diseases Hospital, Kuwait.
    Dimitrov T; Dashti AA; Albaksami O; Jadaon MM
    J Clin Pathol; 2010 Jan; 63(1):83-7. PubMed ID: 19889623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence and properties of fluoroquinolone resistant Salmonella enterica serovar Typhi strains isolated from Nepal in 2002 and 2003.
    Nobthai P; Serichantalergs O; Wongstitwilairoong B; Srijan A; Bodhidatta L; Malla S; Mason CJ
    Southeast Asian J Trop Med Public Health; 2010 Nov; 41(6):1416-22. PubMed ID: 21329318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
    Turner AK; Nair S; Wain J
    J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of mechanisms involved in reduced susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A isolates from travellers to Southeast Asia.
    Hassing RJ; Menezes GA; van Pelt W; Petit PL; van Genderen PJ; Goessens WH
    Int J Antimicrob Agents; 2011 Mar; 37(3):240-3. PubMed ID: 21227657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of fluoroquinolone-resistant strains of Salmonella enterica in Surabaya, Indonesia.
    Yanagi D; de Vries GC; Rahardjo D; Alimsardjono L; Wasito EB; De I; Kinoshita S; Hayashi Y; Hotta H; Osawa R; Kawabata M; Shirakawa T
    Diagn Microbiol Infect Dis; 2009 Aug; 64(4):422-6. PubMed ID: 19631095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First isolation of ciprofloxacin-resistant Salmonella enterica serovar Typhi in Taiwan.
    Lee CJ; Su LH; Huang YC; Chiu CH
    J Microbiol Immunol Infect; 2013 Dec; 46(6):469-73. PubMed ID: 23465712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced susceptibility to ciprofloxacin and gyra gene mutation in North Indian strains of Salmonella enterica serotype Typhi and serotype Paratyphi A.
    Renuka K; Kapil A; Kabra SK; Wig N; Das BK; Prasad VV; Chaudhry R; Seth P
    Microb Drug Resist; 2004; 10(2):146-53. PubMed ID: 15256030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009.
    Menezes GA; Harish BN; Khan MA; Goessens WH; Hays JP
    Clin Microbiol Infect; 2012 Mar; 18(3):239-45. PubMed ID: 21714829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and Paratyphi A isolated in Katmandu, Nepal, in 2003.
    Shirakawa T; Acharya B; Kinoshita S; Kumagai S; Gotoh A; Kawabata M
    Diagn Microbiol Infect Dis; 2006 Apr; 54(4):299-303. PubMed ID: 16466897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug resistance patterns in Salmonella enterica subspecies enterica serotype Typhi strains isolated over a period of two decades, with special reference to ciprofloxacin and ceftriaxone.
    Nath G; Maurya P
    Int J Antimicrob Agents; 2010 May; 35(5):482-5. PubMed ID: 20188522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salmonella enterica serovar typhi: molecular analysis of strains with decreased susceptibility and resistant to ciprofloxacin in India from 2001-2003.
    Capoor MR; Nair D; Aggarwal P; Mathys V; Dehem M; Bifani PJ
    Braz J Infect Dis; 2007 Aug; 11(4):423-5. PubMed ID: 17873998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of mutations in the gyrA gene and class I integron from quinolone-resistant Salmonella enterica serovar Choleraesuis isolates in Taiwan.
    Huang TM; Chang YF; Chang CF
    Vet Microbiol; 2004 Jun; 100(3-4):247-54. PubMed ID: 15145503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones].
    Lei YC; Wang HB; Sun ZY; Shen ZY
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):403-7. PubMed ID: 12820918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of Pefloxacin for detection of fluoroquinolone (FQ) resistance among
    Inayath SB; Broor S; Gupta R; Agarwal P; Majumder S; Anveshi AK; Gaind R
    J Med Microbiol; 2021 Aug; 70(8):. PubMed ID: 34356003
    [No Abstract]   [Full Text] [Related]  

  • 17. Changing trends in antimicrobial resistance of Salmonella enterica serovar typhi and salmonella enterica serovar paratyphi A in Chennai.
    Krishnan P; Stalin M; Balasubramanian S
    Indian J Pathol Microbiol; 2009; 52(4):505-8. PubMed ID: 19805957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
    Slinger R; Desjardins M; McCarthy AE; Ramotar K; Jessamine P; Guibord C; Toye B
    BMC Infect Dis; 2004 Sep; 4():36. PubMed ID: 15380025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the gyrA gene in Salmonella enterica clinical isolates with decreased ciprofloxacin susceptibility.
    Escribano I; Rodríguez JC; Royo G
    Int J Antimicrob Agents; 2004 Sep; 24(3):300-3. PubMed ID: 15325438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and Paratyphi A isolates with decreased susceptibility to ciprofloxacin.
    Misra R; Thakare R; Amrin N; Prasad KN; Chopra S; Dhole TN
    Trans R Soc Trop Med Hyg; 2016 Aug; 110(8):472-9. PubMed ID: 27618918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.